Endothelial dysfunction and its critical role in COVID‐19‐associated coagulopathy: Defibrotide as an endothelium‐protective, targeted therapy

• David García‐Bernal,
• Edward Richardson,
• Israel Vlodavsky,
• Carmelo Carlo‐Stella,
• Massimo Iacobelli,
• Rubén Jara,
• Paul G. Richardson,
• Jose M. Moraleda

Affiliations

David García‐Bernal

Department of Medicine Hematopoietic Transplant and Cellular Therapy Unit IMIB‐Arrixaca Virgen de la Arrixaca University Hospital University of Murcia Murcia Spain

Edward Richardson

Frank H. Netter M.D. School of Medicine Quinnipiac University North Haven Connecticut USA

Israel Vlodavsky

Technion Integrated Cancer Center Rappaport Faculty of Medicine Technion Haifa Israel

Carmelo Carlo‐Stella

Department of Oncology and Hematology Humanitas Clinical and Research Center‐IRCCS Rozzano‐Milano Italy

Massimo Iacobelli

Techitra s.r.l. Milan Italy

Rubén Jara

Intensive Care Unit, Virgen de la Arrixaca University Hospital University of Murcia Murcia Spain

Paul G. Richardson

Division of Hematologic Malignancy Department of Medical Oncology Dana Farber Cancer Institute Harvard Medical School Boston Massachusetts USA

Jose M. Moraleda

Department of Medicine Hematopoietic Transplant and Cellular Therapy Unit IMIB‐Arrixaca Virgen de la Arrixaca University Hospital University of Murcia Murcia Spain